Orthopedic Implant Antibacterial Coatings Surface Treatment Market is expected to reach US$ 178.55 Million by 2028

Published Date: 25 Oct 2021

Report : Orthopedic Implant Antibacterial Coatings Surface Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Passive Surface Finishing/Modifications (PSM), Active Surface Finishing/Modifications (ASM), PeriOperative Antibacterial Local Carriers or Coatings (LCC)); Material Type (Metallic Coatings and Non-Metallic Coatings), and Geography

Rise in Prevalence of Implant-Associated Infections Contribute to Growth of Orthopedic Implant Antibacterial Coatings Surface Treatment Market

 

According to our latest market research study on “Orthopedic Implant Antibacterial Coatings Surface Treatment Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type and Material Type,” the market is expected to reach US$ 178.55 Million by 2028 from US$ 87.15 Million in 2021; it is estimated to register a CAGR of 10.8% from 2021 to 2028. The report highlights the market trends, drivers, and deterrents. The rise in the prevalence of implant-associated infections and technological advancements in antibacterial coatings is driving the market. However, the high cost of implants with antimicrobial coating is hindering market growth.    

 

Based on type, the global orthopedic implant antibacterial coatings surface treatment market is segmented into passive surface finishing/modifications (PSM), active surface finishing/modifications (ASM), and peri-operative antibacterial local carriers or coatings (LCC). In 2020, the active surface finishing/modifications (ASM) segment held the largest share of the market. Furthermore, the same segment is expected to register the highest CAGR in the market during 2021–2028. ASM involves the application of pharmacologically active antibacterial agents or compounds like antibiotics, antiseptics, metal ions, or organic molecules on the surface of orthopedic implants. Such pharmacologically activated coatings on implant surfaces may change the implant from a passive or pharmacologically inert medical device to a drug-loaded medical device. Companies such as DOT GmbH and Harland Medical Systems, Inc. provide antibacterial coatings surface treatment, which is expected to drive the market during the forecast period.    
    

Health care systems are overburdened due to the COVID-19 pandemic, and the delivery of medical care to all patients has become a challenge worldwide. As the COVID-19 pandemic continues to unfold, medical device companies are finding difficulties in managing their operations. Many companies offering products for orthopedic implant antibacterial coatings surface treatment have their business operations in the US, and their business is adversely being negatively affected by the COVID-19 pandemic. This pandemic has disrupted the product distribution, as well as resulted in temporary closures of company facilities. For instance, as per the British Journal of Surgery published in May 2020, orthopedic procedures were affected the most, with 6.3 million operations canceled worldwide due to the pandemic. Moreover, cancellations of elective surgeries to reduce exposure to COVID-19 in the hospital and operating rooms into intensive care units have hampered the growth of the orthopedic implant antibacterial coatings surface treatment market. However, in 2021 as the new COVID-19 cases are going down the as the situation is recovering thus, the market is expected to grow in upcoming days.   

 

The key players operating in the orthopedic implant antibacterial coatings surface treatment market include DOT GmbH; Covalon Technologies Ltd.; Sciessent LLC; Harland Medical Systems, Inc.; Isoflux, Inc.; Allvivo Vascular, Inc.; aap Implantate AG; BASF SE; Agienic Inc.; and ARAN BIOMEDICAL. Companies are adopting organic and inorganic growth strategies to sustain their position in the orthopedic implant antibacterial coatings surface treatment market. In March 2020, Covalon Technologies Ltd. launched its breakthrough antimicrobial technology called CovaGuard, formulated to kill the COVID-19 virus (or “SARS-CoV-2”) and other viruses, bacteria, and pathogens and provide continuous protection by trapping and deactivating microbes over an extended period. CovaGuard can be safely applied on the skin and protective medical equipment.    

 

Orthopedic Implant Antibacterial Coatings Surface Treatment Market, by Region, 2020 (%)

Orthopedic Implant Antibacterial Coatings Surface Treatment Market, by Region, 2020 (%)   

 

The global orthopedic implant antibacterial coatings surface treatment market is segmented into type, material type, and geography. In terms of product, the market is segmented into passive surface finishing/modifications (PSM), active surface finishing/modifications (ASM), and peri-operative antibacterial local carriers or coatings (LCC). Based on material type, the orthopedic implant antibacterial coatings surface treatment market is segmented into metallic coatings and non-metallic coatings. In terms of geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South and Central America.    

 

Contact Us
Contact Person: Sameer Joshi 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com

 
Download Free PDF Brochure